Jagodinsky JC, Jin WJ, Bates AM, Hernandez R, Grudzinski JJ, Marsh IR, Chakravarty I, Arthur IS, Zangl LM, Brown RJ, Nystuen EJ, Emma SE, Kerr C, Carlson PM, Sriramaneni RN, Engle JW, Aluicio-Sarduy E, Barnhart TE, Le T, Kim Okay, Bednarz BP, Weichert JP, Patel RB, Morris ZS. Temporal evaluation of sort 1 interferon activation in tumor cells following exterior beam radiotherapy or focused radionuclide remedy. Theranostics. 2021;11:6120–37.
Grzmil M, Boersema P, Sharma A, Blanc A, Imobersteg S, Pruschy M, Picotti P, Schibli R, Behe M. Comparative evaluation of most cancers cell responses to focused radionuclide remedy (TRT) and exterior beam radiotherapy (EBRT). J Hematol Oncol. 2022;15:123.
Pan S, Huang G, Solar Z, Chen X, Xiang X, Jiang W, Xu Y, Chen T, Zhu X. X-ray-responsive zeolitic imidazolate framework-capped nanotherapeutics for cervical cancer-targeting radiosensitization. Adv Funct Mater. 2023;33:2213364.
Zhang Z, Liu X, Chen D, Yu J. Radiotherapy mixed with immunotherapy: the daybreak of most cancers therapy. Sign Transduct Tar. 2022;7:258.
Gao S, Li T, Guo Y, Solar C, Xianyu B, Xu H. Selenium-containing nanoparticles mix the NK cells mediated immunotherapy with radiotherapy and chemotherapy. Adv Mater. 2020;32:1907568.
McLaughlin M, Patin EC, Pedersen M, Wilkins A, Dillon MT, Melcher AA, Harrington KJ. Inflammatory microenvironment remodelling by tumour cells after radiotherapy. Nat Rev Most cancers. 2020;20:203–17.
Cytlak UM, Dyer DP, Honeychurch J, Williams KJ, Travis MA, Illidge TM. Immunomodulation by radiotherapy in tumour management and regular tissue toxicity. Nat Rev Immunol. 2022;22:124–38.
Solar L, Shen F, Tian L, Tao H, Xiong Z, Xu J, Liu Z. ATP-responsive sensible hydrogel releasing immune adjuvant synchronized with repeated chemotherapy or radiotherapy to spice up antitumor immunity. Adv Mater. 2021;33:2007910.
Deng Z, Liu J, Xi M, Wang C, Fang H, Wu X, Zhang C, Solar G, Zhang Y, Shen L, Chen M, Ji J, Liu Z, Yang G. Biogenic platinum nanoparticles on bacterial fragments for enhanced radiotherapy to spice up antitumor immunity. Nano At this time. 2022;47: 101656.
Duo Y, Chen Z, Li Okay, Yang Y, Wang H, Hu J, Luo G. Focused supply of novel Au(I)-based AIEgen by way of inactivated most cancers cells for trimodal chemo-radio-immunotherapy and vaccination towards superior tumor. Nano At this time. 2023;51: 101920.
Du S, Chen G, Yuan B, Hu Y, Yang P, Chen Y, Zhao Q, Zhou J, Fan J, Zeng Z. DNA sensing and related sort 1 interferon signaling contributes to development of radiation-induced liver damage. Cell Mol Immunol. 2021;18:1718–28.
Liu N, Zhu J, Zhu W, Chen L, Li M, Shen J, Chen M, Wu Y, Pan F, Deng Z, Liu Y, Yang G, Liu Z, Chen Q, Yang Y. X-ray-induced launch of nitric oxide from hafnium-based nanoradiosensitizers for enhanced radio-immunotherapy. Adv Mater. 2023;35:2302220.
Gu J, Liu X, Ji Z, Shen M, Zhu M, Ren Y, Guo L, Yang Okay, Liu T, Yi X. Tumor vascular destruction and cGAS-STING activation induced by single drug-loaded nano-micelles for a number of synergistic therapies of most cancers. Small. 2023;19:2303517.
Xu W, Qiao L, Wang Z, Qian Y, Li L, Solar Q, Li C. Twin-pathway STING activation and chemodynamic remedy for improved anti-tumor remedy. Chem Eng J. 2023;474: 145702.
Cao L, Tian H, Fang M, Xu Z, Tang D, Chen J, Yin J, Xiao H, Shang Okay, Han H, Li X. Activating cGAS-STING pathway with ROS-responsive nanoparticles delivering a hybrid prodrug for enhanced chemo-immunotherapy. Biomaterials. 2022;290: 121856.
Pei P, Zhang Y, Jiang Y, Shen W, Chen H, Yang S, Zhang Y, Yi X, Yang Okay. Pleiotropic immunomodulatory capabilities of radioactive inactivated bacterial vectors for enhanced most cancers radio-immunotherapy. ACS Nano. 2022;16:11325–37.
Sang W, Zhang Z, Wang G, Xie L, Li J, Li W, Tian H, Dai Y. A triple-kill technique for tumor eradication bolstered by metal-phenolic community nanopumps. Adv Funct Mater. 2022;32:2113168.
Wang C, Dong Z, Hao Y, Zhu Y, Ni J, Li Q, Liu B, Han Y, Yang Z, Wan J, Yang Okay, Liu Z, Feng L. Coordination polymer-coated CaCO3 reinforces radiotherapy by reprogramming the immunosuppressive metabolic microenvironment. Adv Mater. 2022;34:2106520.
Zhang P, Rashidi A, Zhao J, Silvers C, Wang H, Castro B, Ellingwood A, Han Y, Lopez-Rosas A, Zannikou M, Dmello C, Levine R, Xiao T, Cordero A, Sonabend AM, Balyasnikova IV, Lee-Chang C, Miska J, Lesniak MS. STING agonist-loaded, CD47/PD-L1-targeting nanoparticles potentiate antitumor immunity and radiotherapy for glioblastoma. Nat Commun. 2023;14:1610.
Li S, Wang Y, Wang X, Feng J, Guo DS, Meng Z, Liu Y, Solar SK, Zhang Z. Macrocyclic-albumin conjugates for exact supply of radionuclides and anticancer medicine to tumors. ACS Nano. 2023;17:22399–409.
Pei P, Shen W, Zhou H, Solar Y, Zhong J, Liu T, Yang Okay. Radionuclide labeled gold nanoclusters increase efficient anti-tumor immunity for augmented radio-immunotherapy of most cancers. Nano At this time. 2021;38: 101144.
Zai W, Kang L, Dong T, Wang H, Yin L, Gan S, Lai W, Ding Y, Hu Y, Wu J, E. Coli membrane vesicles as a catalase provider for long-term tumor hypoxia reduction to reinforce radiotherapy. ACS Nano. 2021;15:15381–94.
Wang H, Liu J, Zhu X, Yang B, He Z, Yao X. AZGP1P2/UBA1/RBM15 cascade mediates the destiny determinations of prostate most cancers stem cells and promotes therapeutic impact of docetaxel in castration-resistant prostate most cancers by way of TPM1 m6A modification. Analysis. 2023;6:0252.
Wang Q, Yang T, Li S, Xu C, Wang C, Xiong Y, Wang X, Wan J, Yang X, Li Z. Unimolecular self-assembled hemicyanine–oleic acid conjugate acts as a novel succinate dehydrogenase inhibitor to amplify photodynamic remedy and remove most cancers stem cells. Analysis. 2023;6:0223.
Zhang C, Yuan Y, Wu Okay, Wang Y, Zhu S, Shi J, Wang L, Li Q, Zuo X, Fan C, Chang C, Li J. Driving DNA origami meeting with a terahertz wave. Nano Lett. 2022;22:468–75.
Wang Y, Chen J, Duan R, Gu R, Wang W, Wu J, Lian H, Hu Y, Yuan A. Excessive-Z-sensitized radiotherapy synergizes with the intervention of the pentose phosphate pathway for in situ tumor vaccination. Adv Mater. 2022;34:2109726.
Dai X, Ruan J, Guo Y, Solar Z, Liu J, Bao X, Zhang H, Li Q, Ye C, Wang X, Zhao C-X, Zhou F, Sheng J, Chen D, Zhao P. Enhanced radiotherapy efficacy and induced anti-tumor immunity in HCC by enhancing hypoxia microenvironment utilizing oxygen microcapsules. Chem Eng J. 2021;422: 130109.
Dong Z, Wang C, Gong Y, Zhang Y, Fan Q, Hao Y, Li Q, Wu Y, Zhong X, Yang Okay, Feng L, Liu Z. Chemical modulation of glucose metabolism with a fluorinated CaCO3 nanoregulator can potentiate radiotherapy by programming antitumor immunity. ACS Nano. 2022;16:13884–99.
Zhang C, Xia D, Liu J, Huo D, Jiang X, Hu Y. Bypassing the Immunosuppression of myeloid-derived suppressor cells by reversing tumor hypoxia utilizing a platelet-inspired platform. Adv Funct Mater. 2020;30:2000189.
Huang H, Zhang C, Wang X, Shao J, Chen C, Li H, Ju C, He J, Gu H, Xia D. Overcoming hypoxia-restrained radiotherapy utilizing an erythrocyte-inspired and glucose-activatable platform. Nano Lett. 2020;20:4211–9.
Zhang C, Ren J, Hua J, Xia L, He J, Huo D, Hu Y. Multifunctional Bi2WO6 nanoparticles for CT-guided photothermal and oxygen-free photodynamic remedy. ACS Appl Mater Interfaces. 2018;10:1132–46.
Zuo H, Tao J, Shi H, He J, Zhou Z, Zhang C. Platelet-mimicking nanoparticles co-loaded with W18O49 and metformin alleviate tumor hypoxia for enhanced photodynamic remedy and photothermal remedy. Acta Biomater. 2018;80:296–307.
Jiang W, Wang L, Wang Q, Zhou H, Ma Y, Dong W, Xu H, Wang Y. Reversing immunosuppression in hypoxic and immune-cold tumors with ultrathin oxygen self-supplementing polymer nanosheets beneath close to infrared gentle irradiation. Adv Funct Mater. 2021;31:2100354.
Liu X, Ye N, Liu S, Guan J, Deng Q, Zhang Z, Xiao C, Ding ZY, Zhang BX, Chen XP, Li Z, Yang X. Hyperbaric oxygen boosts PD-1 antibody supply and T cell infiltration for augmented immune responses towards strong tumors. Adv Sci. 2021;8:2100233.
McGettrick AF, O’Neill LAJ. The position of HIF in immunity and irritation. Cell Metab. 2020;32:524–36.
Liu X, Yi X, Gu J, Ji Z, Zhu M, Shen M, Ren Y, Guo L, Liu T, Ding N, Yang Okay. Immunoregulatory liposomes hitchhiking on neutrophils for enhanced carbon ion radiotherapy-assisted immunotherapy of glioblastoma. Nano At this time. 2023;53: 102037.
Zhang C, Jing X, Guo L, Cui C, Hou X, Zuo T, Liu J, Shi J, Liu X, Zuo X, Li J, Chang C, Fan C, Wang L. Distant photothermal management of DNA origami meeting in mobile environments. Nano Lett. 2021;21:5834–41.
Zetrini AE, Lip HY, Abbasi AZ, Alradwan I, Ahmed T, He C, Henderson JT, Rauth AM, Wu XY. Transforming tumor immune microenvironment through the use of polymer-lipid-manganese dioxide nanoparticles with radiation remedy to spice up immune response of castration-resistant prostate most cancers. Analysis. 2023;6:0247.
Guo Q, Li X, Zhou W, Chu Y, Chen Q, Zhang Y, Li C, Chen H, Liu P, Zhao Z, Wang Y, Zhou Z, Luo Y, Li C, You H, Music H, Su B, Zhang T, Solar T, Jiang C. Sequentially triggered bacterial outer membrane vesicles for macrophage metabolism modulation and tumor metastasis suppression. ACS Nano. 2021;15:13826–38.
Qing S, Lyu C, Zhu L, Pan C, Wang S, Li F, Wang J, Yue H, Gao X, Jia R, Wei W, Ma G. Biomineralized bacterial outer membrane vesicles potentiate protected and environment friendly tumor microenvironment reprogramming for anticancer remedy. Adv Mater. 2020;32:2002085.
Chen Q, Bai H, Wu W, Huang G, Li Y, Wu M, Tang G, Ping Y. Bioengineering bacterial vesicle-coated polymeric nanomedicine for enhanced most cancers immunotherapy and metastasis prevention. Nano Lett. 2020;20:11–21.
Yi X, Zhou HL, Chao Y, Xiong SS, Zhong J, Chai ZF, Yang Okay, Liu Z. Micro organism-triggered tumor-specific thrombosis to allow potent photothermal immunotherapy of most cancers. Sci Adv. 2020;6:eaba3546.
Huang X, Pan J, Xu F, Shao B, Wang Y, Guo X, Zhou S. Micro organism-based most cancers immunotherapy. Adv Sci. 2021;8:2003572.
Lv M, Chen M, Zhang R, Zhang W, Wang C, Zhang Y, Wei X, Guan Y, Liu J, Feng Okay, Jing M, Wang X, Liu YC, Mei Q, Han W, Jiang Z. Manganese is crucial for antitumor immune responses by way of cGAS-STING and improves the efficacy of scientific immunotherapy. Cell Res. 2020;30:966–79.
Ding L, Liang M, Li Y, Zeng M, Liu M, Ma W, Chen F, Li C, Reis RL, Li FR, Wang Y. Zinc-organometallic framework vaccine controlled-release Zn2+ regulates tumor extracellular matrix degradation potentiate efficacy of immunotherapy. Adv Sci. 2023;10:2302967.
Zhao X, Cheng H, Wang Q, Nie W, Yang Y, Yang X, Zhang Okay, Shi J, Liu J. Regulating photosensitizer metabolism with DNAzyme-loaded nanoparticles for amplified mitochondria-targeting photodynamic immunotherapy. ACS Nano. 2023;17:13746–59.
Chen Q, Feng L, Liu J, Zhu W, Dong Z, Wu Y, Liu Z. Clever albumin-MnO2 nanoparticles as pH-/H2O2-responsive dissociable nanocarriers to modulate tumor hypoxia for efficient mixture remedy. Adv Mater. 2016;28:7129–36.
Tian L, Chen Q, Yi X, Chen J, Liang C, Chao Y, Yang Okay, Liu Z. Albumin-templated manganese dioxide nanoparticles for enhanced radioisotope remedy. Small. 2017;13:1700640.
Deng Z, Xi M, Zhang C, Wu X, Li Q, Wang C, Fang H, Solar G, Zhang Y, Yang G, Liu Z. Biomineralized MnO2 nanoplatforms mediated supply of immune checkpoint inhibitors with STING pathway activation to potentiate most cancers radio-immunotherapy. ACS Nano. 2023;17:4495–506.
